Processa Pharmaceuticals, Inc. Crypto Asset Realized And Unrealized Loss Operating
Processa Pharmaceuticals, Inc. (PCSA) reported Crypto Asset Realized And Unrealized Loss Operating of $59.82 thousand for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-07.
Financial Statements › Notes › Goodwill and Other
us-gaap:CryptoAssetRealizedAndUnrealizedLossOperating · last filed 2026-05-07
- Processa Pharmaceuticals, Inc. crypto asset realized and unrealized loss operating for the quarter ending 2026-03-31 was $59.82K.
| Period end | Crypto Asset Realized And Unrealized Loss Operating 3 month |
|---|---|
| 2026-03-31 | $59.82K 10-Q · filed 2026-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |